The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Actually OS my quotes came from an RNS, so regulated by the FCA and from our NOMAD, if you totally mistrust those sources then you really shouldn't be here. Then again I'm not the first nor I suspect the last to give you that advice.
and while I'm on one I can quote "Aggregate level of customer enquiries well exceeds the full capacity of these production lines, with the top 10 prospects exceeding 9 million units per annum". Are Customers interested? Well, Yes.
Hmmm. True I don't have any real hard evidence of the exact numbers, AK doesn't share his order book with me, neither did Murata and I have resisted hacking into their systems because it would be illegal without their permission which oddly enough I don't have. But I can quote "Management reports high levels of interest from both pre-existing Murata customers and new prospects for the output of the new production lines". Do some research ffs. Why is it you think you can require everyone else to provide irrefutable evidence for everything they post at the same time believe you are free to post fabricated negativity without any actual basis for it. It is a board for sharing views not a court of law. Why not do some research before you post you negativity, so you don't continue to look foolish. Try a positive post without a negative follow up. Why not start by congratulating AK on the transformational Murata project?
I understand Musk is a successful out of the box creative thinker and Entrepreneur trying to save the World. You think that is so for Trump too? Not the same by a long chalk in my book. Musk bought out Maxwell to get their Tech, so obviously he isn't against that as a strategy. He could buy us with the money behind his sofa, or he could pay his way on a license or he can risk having everything impounded if the case is going our way. Have you read the patents? They are very simple, very basic, easy to judge in my book. CPX have already said they will choose their battles carefully. Yet Musk isn't the judge and jury, he has to work within the law. Just because he was happy to give up some of his patents to make electric cars commonplace to cut CO2 doesn't give him the right to steal other's IP and I don't think he has ever said so. Also I for one wouldn't try to second guess someone with his abilities. OS having lost completely lost the arguments over saying AK could never pull of the Murata production line project, CPX would never make a profit, is now trying to stir up more new negativity on something he really hasn't researched and doesn't understand. I do agree with OS one thing though. He hasn't a clue, he just enjoys what he thinks is banter. All IMO. I have to declare an interest though , I have happily been invested in both CAP-XX and Tesla for a long time.
That has to be a very exciting update. Given the logistical nightmare around handling the Pfizer Covid vaccine et al Nigel's phone should be red hot today. But what will the market make of it? Spike up and then return to 6-7p. Surely it will wake up one day to what is going on here.
Quite right TD, there are many reasons why my estimate of 11p from end of June 20 is far too low. By way of corroboration, assume that outside of the ex-Murata production line we break even, as per End of June figures. Then we have been told there are orders that exceed 9mm units for the new line. Lets play safe and assume an average of GBP1 profit per item (so GBP2 sales cost). GBP9mm profit gives an SP of about 25p. That is now! then add on all those other things. Anyone get to find out if 9mm capacity was single shift, split shift or 24/7 or however else Aussies like to work? Anyone want to update the average selling price of GBP2?
A summary of my calculations for end of June 20 show that the cost of sales (A$6.1) + Cost of legals (A$0.67) approx = income from sales + R&D rebate (A$6.8). Then factor in Murata customer orders @ A$14mmpa at 53% profit would return a profit of GBP4.1mm. which equates to something like 11p per share but that would be End of June 20 plus Murata. Then add double the order book at end of June YOY, the new production line at capacity(!), orders up 10% in the last three weeks, sitting on the IOXUS US$5mm award plus costs, progress in licensing and the Maxwell ADR, I would think 20p would look cheap this time next year. SouthCumbria could be very close at a targer of 30p. There is no cash flow issue to concern the sp. All IMO from the back of my fag packet (which I haven't needed to buy a new one of for the last 24 years!), think my currencies and conversions are good.
Maybe it works the other way round OS, seeing you tie yourself in sanctimonious knots has been easy game. Anyway now that AK has proven to you that is is keen on manufacturing too as well as groundbreaking R&D, can run projects to time and under budget, has had a perfect score to date protecting our IP, is now taking the company into profit and has rapidly expanding order book just maybe once in a while you might see your way into posting something positive instead of fabricating continual negativity? Balance indeed.